Medicine and Dentistry
Epileptic Seizure
61%
Status Epilepticus
61%
Magnetic Resonance Imaging
27%
Partial Seizure
26%
Prevalence
25%
Cohort Analysis
19%
Global Disease Burden
19%
Cardiovascular Disease
18%
Functional Magnetic Resonance Imaging
14%
Epilepsy Syndromes
13%
Diseases
11%
Seizure Types
11%
Atherosclerosis
11%
Neurology
11%
General Anesthesia
11%
Drug Resistant Epilepsy
10%
Post-Hoc Analysis
10%
Superficial Siderosis
9%
Marfan Syndrome
9%
Synaptopathy
9%
DLG4
9%
Finger Dermatoglyphics
9%
Motor Vehicle Accident
9%
Vascular Amyloidosis
9%
Paralysis
9%
Radial Nerve
9%
Epileptogenesis
9%
Health Care
9%
Electroconvulsive Therapy
9%
Epilepsy Surgery
9%
Diagnostic Accuracy
9%
Patient with Epilepsy
9%
Treatment Response
9%
Case-Control Study
9%
Patient-Data
9%
Prophylaxis
9%
Nonalcoholic Fatty Liver
9%
Beck Depression Inventory
9%
Outpatient
9%
Susceptibility Weighted Imaging
9%
Eslicarbazepine Acetate
9%
Brain Disease
9%
Life Expectancy
9%
Cannabis
9%
Virus RNA
9%
Tick Borne Encephalitis Virus
9%
Tick Borne Encephalitis
9%
Attitude
9%
Carbamazepine
9%
Monotherapy
9%
Spinal Cord Injury
9%
Locked-in Syndrome
9%
Disorders of Consciousness
9%
Allergic Encephalitis
9%
Infectious Encephalitis
9%
Restless Legs Syndrome
9%
Observational Study
9%
Emergency Department
9%
Myoclonus
9%
Frontal Lobe Epilepsy
9%
Cannabidiol
9%
Coronary Artery Calcium
9%
Infection
8%
Benzodiazepine
8%
Biological Marker
7%
Fatty Liver
7%
Thalamus
7%
Population
6%
Glial Fibrillary Acidic Protein
6%
Light Chain
6%
Coronary Artery Calcification
6%
Systematic Review
6%
Apoplexy
6%
Low Density Lipoprotein Cholesterol
5%
Clinical Trial
5%
Generalised Epilepsy
5%
Neuroscience
Status Epilepticus
100%
Electroencephalography
31%
Focal Epilepsy
24%
Juvenile Myoclonic Epilepsy
19%
Tinnitus
19%
Cerebral Amyloid Angiopathy
19%
Behavior (Neuroscience)
16%
Magnetic Resonance Imaging
15%
Central Nervous System
14%
Magnetoencephalography
13%
Ictal
12%
Beck Depression Inventory
11%
Face
11%
Neurosurgery
11%
Seizure Types
10%
Slow-Wave Sleep
10%
Anterior Cingulate Cortex
10%
Temporal Lobe Epilepsy
10%
Supplementary Motor Area
9%
Epileptic Seizure
9%
Eslicarbazepine Acetate
9%
Carbamazepine
9%
Cochlea
9%
Nerve Conduction
9%
Eye Movement
9%
Pathological Gambling
9%
Electroconvulsive Therapy
9%
Cotard Delusion
9%
Sodium Valproate
9%
Verbal Memory
9%
Epileptogenesis
9%
Learning Disabilities
9%
Locked-in Syndrome
9%
DLG4
9%
Brain Disease
9%
Intracranial Tumor
9%
Encephalitis
9%
Rheumatoid Arthritis
9%
Frontal Lobe Epilepsy
9%
Dura Mater
9%
Depression
9%
Magnetic Resonance Imaging of Brain
8%
Speech Processing
8%
Ventromedial Prefrontal Cortex
7%
Thalamus
7%
Cerebrovascular Accident
7%
Functional Magnetic Resonance Imaging
6%
Transcranial Magnetic Stimulation
6%
Low Density Lipoprotein Cholesterol
5%
Hippocampus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Epileptic State
59%
Focal Epilepsy
24%
Cohort Study
19%
Nonalcoholic Fatty Liver
19%
Tolerability
16%
Prevalence
16%
Clinical Trial
11%
Adverse Event
10%
Life Expectancy
9%
Perampanel
9%
Disease
9%
Alcohol Intoxication
9%
Systemic Disease
9%
Epileptogenesis
9%
Cannabis
9%
Spinal Cord Injury
9%
Survival Rate
9%
Global Disease Burden
9%
Eslicarbazepine Acetate
9%
Carbamazepine
9%
Monotherapy
9%
Drug Intoxication
9%
Cardiovascular Disease
9%
Stiripentol
9%
Infectious Encephalitis
9%
Allergic Encephalitis
9%
Tinnitus
9%
Restless Legs Syndrome
9%
Observational Study
9%
Carotid Atherosclerosis
9%
Cannabidiol
9%
Multiple Sclerosis
9%
Transient Global Amnesia
9%
Tonic Clonic Seizure
8%
Fatty Liver
7%
Biological Marker
6%
Glial Fibrillary Acidic Protein
6%
Coronary Artery Calcification
6%
Low Density Lipoprotein Cholesterol
5%
Hearing Impairment
5%
Generalised Epilepsy
5%